Corvus 制药 CRVS
$10.54 +$0.81 (+8.32%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $10.60 +0.57%
开盘$10.65
昨收$9.73
当日区间$9.64 – $10.96
成交量1.26M
市值$889.08M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$19.30M-88.1% YoY
净利润-$17.96M-124.5% YoY
摊薄每股收益-$0.19-90.0% YoY
自由现金流-$15.98M-171.3% YoY
经营现金流-$15.40M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-35.4%
资产收益率-32.9%
投入资本回报率-38.6%
流动比率16.16
负债/资产比率5.8%
现金及投资$215.23M
总负债$274,000.00
净现金（净负债）$214.95M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $19.30M | $14.88M | $42.97M | $12.22M | $10.57M |
| 销售及管理费用 | $3.33M | $3.70M | $9.25M | $2.28M | $2.12M |
| -管理费用 | $3.33M | $3.70M | $9.25M | $2.28M | $2.12M |
| 研发费用 | $15.96M | $11.18M | $33.72M | $9.94M | $8.45M |
| 营业利润 | -$19.30M | -$14.88M | -$42.97M | -$12.22M | -$10.57M |
| 非经营性利息净收入（支出） | $2.05M | $1.78M | $2.51M | $603,000.00 | $738,000.00 |
| 非经营性利息收入 | $2.05M | $1.78M | $2.51M | $603,000.00 | $738,000.00 |
| 其他收入（支出） | -$709,000.00 | -$599,000.00 | $25.18M | -$707,000.00 | -$323,000.00 |
| 权益法投资收益 | -$709,000.00 | -$599,000.00 | -$1.96M | -$707,000.00 | -$323,000.00 |
| 税前利润 | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| 净利润 | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| 持续经营利润 | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| 归属母公司净利润 | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| 归属普通股股东净利润 | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| 基本每股收益 | -$0.19 | -$0.15 | -$0.19 | -$0.15 | -$0.12 |
| 摊薄每股收益 | -$0.19 | -$0.15 | -$0.53 | -$0.15 | -$0.12 |
| 证券出售收益 | – | – | $27.14M | $0.00 | – |
| 特殊收益（费用） | – | – | $0.00 | – | – |
| -固定资产出售收益 | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $239.27M | $253.20M | $71.12M | $71.12M | $80.47M |
| 流动资产合计 | $220.97M | $239.95M | $58.21M | $58.21M | $66.94M |
| 现金及现金等价物与短期投资 | $215.23M | $236.71M | $56.75M | $56.75M | $65.69M |
| -现金及现金等价物 | $18.91M | $40.10M | $4.58M | $4.58M | $2.87M |
| -短期投资 | $196.32M | $196.61M | $52.17M | $52.17M | $62.82M |
| 应收款 | $1.85M | $1.20M | $374,000.00 | $374,000.00 | $346,000.00 |
| -应收账款 | $6,000.00 | $43,000.00 | $37,000.00 | $37,000.00 | $32,000.00 |
| -应计应收利息 | $1.84M | $1.16M | $337,000.00 | $337,000.00 | $314,000.00 |
| 预付资产 | $3.31M | $1.67M | $772,000.00 | $772,000.00 | $400,000.00 |
| 其他流动资产 | $575,000.00 | $367,000.00 | $318,000.00 | $318,000.00 | $509,000.00 |
| 非流动资产合计 | $18.31M | $13.25M | $12.91M | $12.91M | $13.53M |
| 固定资产净值 | $1.49M | $1.03M | $1.06M | $1.06M | $1.15M |
| -固定资产原值 | $4.20M | $3.71M | $3.71M | $3.71M | $3.77M |
| -累计折旧 | -$2.71M | -$2.68M | -$2.65M | -$2.65M | -$2.62M |
| 投资及预付款 | $15.11M | $10.50M | $10.99M | $10.99M | $11.53M |
| -长期股权投资 | $15.11M | $10.50M | $10.99M | $10.99M | $11.53M |
| 其他非流动资产 | $1.71M | $1.72M | $855,000.00 | $855,000.00 | $852,000.00 |
| 负债合计 | $13.95M | $12.52M | $9.91M | $9.91M | $8.71M |
| 流动负债合计 | $13.67M | $12.11M | $9.38M | $9.38M | $8.07M |
| 应付款 | $4.05M | $4.70M | $2.49M | $2.49M | $1.97M |
| -应付账款 | $4.05M | $4.70M | $2.49M | $2.49M | $1.97M |
| 一年内应计费用 | $6.94M | $5.40M | $5.61M | $5.61M | $4.44M |
| 短期债务及融资租赁负债 | $454,000.00 | $428,000.00 | $403,000.00 | $403,000.00 | $379,000.00 |
| -一年内到期融资租赁负债 | $454,000.00 | $428,000.00 | $403,000.00 | $403,000.00 | $379,000.00 |
| 其他流动负债 | $299,000.00 | $206,000.00 | $238,000.00 | $238,000.00 | $566,000.00 |
| 非流动负债合计 | $274,000.00 | $406,000.00 | $534,000.00 | $534,000.00 | $632,000.00 |
| 长期债务及融资租赁负债 | $274,000.00 | $406,000.00 | $534,000.00 | $534,000.00 | $632,000.00 |
| -长期融资租赁负债 | $274,000.00 | $406,000.00 | $534,000.00 | $534,000.00 | $632,000.00 |
| 股东权益合计 | $225.33M | $240.68M | $61.21M | $61.21M | $71.77M |
| 股东权益 | $225.33M | $240.68M | $61.21M | $61.21M | $71.77M |
| 股本 | $8,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| -普通股 | $8,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $670.56M | $667.78M | $474.39M | $474.39M | $472.79M |
| 留存收益 | -$443.94M | -$425.99M | -$412.29M | -$412.29M | -$399.97M |
| 不影响留存收益的损益 | -$1.29M | -$1.13M | -$896,000.00 | -$896,000.00 | -$1.06M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$15.40M | -$10.37M | -$32.80M | -$9.19M | -$9.57M |
| 持续经营经营活动现金流净额 | -$15.40M | -$10.37M | -$32.80M | -$9.19M | -$9.57M |
| 持续经营净利润 | -$17.96M | -$13.69M | -$15.28M | -$12.32M | -$10.16M |
| 持续经营损益 | $709,000.00 | $599,000.00 | -$25.18M | $707,000.00 | $323,000.00 |
| 折旧、折耗与摊销 | $34,000.00 | $29,000.00 | $105,000.00 | $26,000.00 | $28,000.00 |
| 营运资金变动 | -$976,000.00 | $57,000.00 | $3.58M | $1.08M | -$550,000.00 |
| -应收款变动 | $37,000.00 | -$6,000.00 | $38,000.00 | -$5,000.00 | $54,000.00 |
| -预付资产变动 | -$2.54M | -$1.76M | $941,000.00 | -$204,000.00 | $64,000.00 |
| -应付账款及应计费用变动 | $1.54M | $2.71M | $2.67M | $1.28M | -$455,000.00 |
| -其他流动资产变动 | $99,000.00 | -$777,000.00 | $115,000.00 | $85,000.00 | -$141,000.00 |
| -其他流动负债变动 | -$106,000.00 | -$103,000.00 | -$185,000.00 | -$74,000.00 | -$72,000.00 |
| 投资活动现金流净额 | -$5.97M | -$144.85M | -$7.80M | $10.88M | -$2.62M |
| 持续经营投资活动现金流净额 | -$5.97M | -$144.85M | -$7.80M | $10.88M | -$2.62M |
| 固定资产购置及出售净额 | -$582,000.00 | -$91,000.00 | -$174,000.00 | -$25,000.00 | $0.00 |
| 投资购置及出售净额 | -$383,000.00 | -$144.76M | -$7.62M | $10.91M | -$2.62M |
| 筹资活动现金流 | $166,000.00 | $190.75M | $36.43M | $20,000.00 | $360,000.00 |
| 持续经营筹资活动现金流净额 | $166,000.00 | $190.75M | $36.43M | $20,000.00 | $360,000.00 |
| 普通股发行净额 | $0.00 | $189.41M | $0.00 | $0.00 | $0.00 |
| 股票期权行使所得 | $166,000.00 | $1.34M | $36.43M | $20,000.00 | $360,000.00 |
| 期末现金余额 | $18.91M | $40.10M | $4.58M | $4.58M | $2.87M |
| 现金净变动 | -$21.20M | $35.53M | -$4.16M | $1.71M | -$11.82M |
| 期初现金余额 | $40.10M | $4.58M | $8.74M | $2.87M | $14.69M |
| 自由现金流 | -$15.98M | -$10.47M | -$32.97M | -$9.22M | -$9.57M |
暂无评论——快来第一个聊聊 CRVS。